Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

RNA Polymerase II Accessory Proteins02:36

RNA Polymerase II Accessory Proteins

Proteins that regulate transcription can do so either via direct contact with RNA Polymerase or through indirect interactions facilitated by adaptors, mediators, histone-modifying proteins, and nucleosome remodelers. Direct interactions to activate transcription is seen in bacteria as well as in some eukaryotic genes. In these cases, upstream activation sequences are adjacent to the promoters, and the activator proteins interact directly with the transcriptional machinery. For example, in...
Cooperative Binding of Transcription Regulators02:13

Cooperative Binding of Transcription Regulators

Transcriptional regulators bind to specific cis-regulatory sequences in the DNA to regulate gene transcription. These cis-regulatory sequences are very short, usually less than ten nucleotide pairs in length. The short length means that there is a high probability of the exact same sequence randomly occurring throughout the genome.  Since regulators can also bind to groups of similar sequences, this further increases the chances of random binding. Transcriptional regulators form dimers that...
Co-activators and Co-repressors02:04

Co-activators and Co-repressors

Gene transcription is regulated by the synergistic action of several proteins that form a complex at a gene regulatory site. This is observed in eukaryotes, where the regulation of gene expression is a complex process. Regulatory proteins in eukaryotes can broadly be classified into two types – regulators that bind directly to specific DNA sequences and co-regulators that associate with regulatory proteins but cannot directly bind to the DNA. These co-regulators are further divided into...
Eukaryotic Transcription Inhibitors01:52

Eukaryotic Transcription Inhibitors

Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...
Cooperative Binding of Transcription Regulators02:13

Cooperative Binding of Transcription Regulators

Transcriptional regulators bind to specific cis-regulatory sequences in the DNA to regulate gene transcription. These cis-regulatory sequences are very short, usually less than ten nucleotide pairs in length. The short length means that there is a high probability of the exact same sequence randomly occurring throughout the genome.  Since regulators can also bind to groups of similar sequences, this further increases the chances of random binding. Transcriptional regulators form dimers that...
Co-activators and Co-repressors02:04

Co-activators and Co-repressors

Gene transcription is regulated by the synergistic action of several proteins that form a complex at a gene regulatory site. This is observed in eukaryotes, where the regulation of gene expression is a complex process. Regulatory proteins in eukaryotes can broadly be classified into two types – regulators that bind directly to specific DNA sequences and co-regulators that associate with regulatory proteins but cannot directly bind to the DNA. These co-regulators are further divided into...

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

Study of the Beta Spectrum Shape of ^{92}Rb and ^{142}Cs Decays for the Prediction of Reactor Antineutrino Spectra.

Physical review letters·2025
Same author

Reliability of hemostasis biomarkers is affected by time-dependent intra-patient variability.

Journal of thrombosis and haemostasis : JTH·2018
Same author

Reflection on the measurement and use of the topography of the indentation imprint.

Scanning·2013
Same author

Structure and dynamics of the tetrameric mnt repressor and a model for its DNA complex.

Journal of biomolecular structure & dynamics·2012
Same author

NMR structure determination of the tetramerization domain of the Mnt repressor: An asymmetric alpha-helical assembly in slow exchange.

Journal of biomolecular NMR·2010
Same author

Protein-Protein Interactions in DNA Recognition: H-NMR Studies of Lambda cI Repressors Genetically Altered by Site-Directed Mutagenesis.

Biophysical journal·2009

関連する実験動画

Updated: Jun 23, 2026

Repressing Gene Transcription by Redirecting Cellular Machinery with Chemical Epigenetic Modifiers
10:28

Repressing Gene Transcription by Redirecting Cellular Machinery with Chemical Epigenetic Modifiers

Published on: September 20, 2018

抑制剤のDNA結合特異性を変化させる.

P Youderian, A Vershon, S Bouvier

    Cell
    |December 1, 1983
    PubMed
    まとめ

    研究者らは,Mnt抑制タンパク質の特定の変異を特定し,そのDNA結合特異性を変化させた. このサルモネラファグP22抑制剤は,突然変異したオペレータをオリジナルよりも強く結合させ,その遺伝的認識における重要な変化を示しています.

    科学分野:

    • 分子生物学は分子生物学である.
    • 遺伝学 遺伝学とは
    • ウイルス学 ウイルス学 ウイルス学

    背景:

    • サルモネラファグP22からのMnt抑制剤は,特定のオペレータDNA配列に結合することによって,遺伝子発現を調節するために重要である.
    • 抑制剤-オペレータの相互作用を理解することは,ウイルスの遺伝子制御メカニズムを解読する鍵です.

    研究 の 目的:

    • Mnt抑制器の特定の変異がDNA結合特異性にどのように影響するか調査する.
    • 結合親和性と特異性の変化に起因するアミノ酸の変化を特定する.

    主な方法:

    • 変異したMnt結合部位の構築,対称,オペレーター構成変異.
    • 変更された結合偏好を持つMnt抑制剤変異体の選択.
    • 純化された野生型および変異Mntタンパク質を用いたインビトロDNA結合アッセイ.

    主要な成果:

    • Mnt抑制器のCACコドン (His6からPro) の変異は,DNA結合特異性の有意な変化をもたらした.
    • ワイルドタイプのMntはワイルドタイプのオペレータを強く結合するが,変異型のオペレータは1000倍少ない afinityで結合する.
    • 変異したMntタンパク質は,変異したオペレータを好む逆の結合親和性を示した.

    さらに関連する動画

    Lentiviral Vector Platform for the Efficient Delivery of Epigenome-editing Tools into Human Induced Pluripotent Stem Cell-derived Disease Models
    13:47

    Lentiviral Vector Platform for the Efficient Delivery of Epigenome-editing Tools into Human Induced Pluripotent Stem Cell-derived Disease Models

    Published on: March 29, 2019

    In Vitro Selection of Engineered Transcriptional Repressors for Targeted Epigenetic Silencing
    10:44

    In Vitro Selection of Engineered Transcriptional Repressors for Targeted Epigenetic Silencing

    Published on: May 5, 2023

    関連する実験動画

    Last Updated: Jun 23, 2026

    Repressing Gene Transcription by Redirecting Cellular Machinery with Chemical Epigenetic Modifiers
    10:28

    Repressing Gene Transcription by Redirecting Cellular Machinery with Chemical Epigenetic Modifiers

    Published on: September 20, 2018

    Lentiviral Vector Platform for the Efficient Delivery of Epigenome-editing Tools into Human Induced Pluripotent Stem Cell-derived Disease Models
    13:47

    Lentiviral Vector Platform for the Efficient Delivery of Epigenome-editing Tools into Human Induced Pluripotent Stem Cell-derived Disease Models

    Published on: March 29, 2019

    In Vitro Selection of Engineered Transcriptional Repressors for Targeted Epigenetic Silencing
    10:44

    In Vitro Selection of Engineered Transcriptional Repressors for Targeted Epigenetic Silencing

    Published on: May 5, 2023

    結論:

    • Mnt抑制器におけるHis6からProの置換は,DNA結合特異性にとって極めて重要です.
    • この研究は,標的型変異が抑制剤-DNAの相互作用を再プログラムする方法を示しています.
    • 発見は,ファグ抑制器における配列認識の分子基礎についての洞察を提供します.